BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7421226)

  • 1. A possible method for the detection of ovulation and the determination of the duration of the fertile period.
    Baker TS; Jennison K; Kellie AE
    J Steroid Biochem; 1980 Jan; 12():411-5. PubMed ID: 7421226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of ovulation by urinary estrogen assays.
    Adlercreutz H; Lehtinen T; Kairento AL
    J Steroid Biochem; 1980 Jan; 12():395-401. PubMed ID: 7421224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The measurement of urinary steroid glucuronides as indices of the fertile period in women. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, special programme of research, development and research training in human reproduction.
    Adlercreutz H; Brown J; Collins W; Goebelsman U; Kellie A; Campbell H; Spieler J; Braissand G
    J Steroid Biochem; 1982 Dec; 17(6):695-702. PubMed ID: 7176659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation prediction: changes in the concentrations of urinary estrone-3-glucuronide, estradiol-17 beta-glucuronide and estriol-16 alpha-glucuronide during conceptional cycles.
    Branch CM; Collins PO; Collins WP
    J Steroid Biochem; 1982 Feb; 16(2):345-7. PubMed ID: 7078170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate, and estriol-16 alpha-glucosiduronate. Significance of proportionate differences during the menstrual cycle.
    Wright K; Collins DC; Preedy JR
    Steroids; 1979 Oct; 34(4):445-57. PubMed ID: 229588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct radioimmunoassay for estriol-16-glucuronide in urine for monitoring pregnancy and induction of ovulation.
    Haning RV; Satin KP; Lynskey MT; Levin RM; Speroff L
    Am J Obstet Gynecol; 1977 Aug; 128(7):793-802. PubMed ID: 879247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct radioimmunoassay of oestrogen glucuronides in human female urine.
    Baker TS; Jennison KM; Kellie AE
    Biochem J; 1979 Feb; 177(2):729-38. PubMed ID: 435263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of ovarian function using first morning urine steroid assays.
    Denari JH; Farinati Z; Casas PR; Oliva A
    Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring induction of ovulation by rapid radioimmunoassays of oestrogen and pregnanediol glucuronides.
    MacLean AR; Outch KH; Russell JM; Brown JB; Dennis PM
    Ann Clin Biochem; 1981 Nov; 18(Pt 6):343-9. PubMed ID: 7316453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An estrogen test to determine the times of potential fertility in women.
    Schiphorst LE; Collins WP; Royston JP
    Fertil Steril; 1985 Sep; 44(3):328-34. PubMed ID: 3896861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical tests of potential fertility.
    Collins WP
    Biochem Soc Trans; 1992 Feb; 20(1):234-7. PubMed ID: 1633952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women.
    Fraser HM; Dewart PJ; Smith SK; Cowen GM; Sandow J; McNeilly AS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):996-1002. PubMed ID: 2507572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the dual-analyte enzyme immunoassay for ovulation timing.
    Lenton EA; King H; Johnson J; Amos S
    Hum Reprod; 1989 May; 4(4):378-80. PubMed ID: 2663906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relationships between indices of the fertile period.
    Fertil Steril; 1983 May; 39(5):647-55. PubMed ID: 6840308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.